Cogent Biosciences Inc. (COGT)
undefined
undefined%
At close: undefined
8.15
-0.85%
After-hours Dec 13, 2024, 04:15 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -192.41M -140.24M -72.27M -74.81M -31.83M -34.53M -25.49M -18.12M -6.59M
Depreciation & Amortization 3.59M 5.88M 147.00K 720.00K 1.29M 1.32M 1.17M 830.00K 179.00K
Stock-Based Compensation 30.62M 18.37M 11.69M 6.02M 3.24M 3.09M 1.34M 1.02M 248.00K
Other Working Capital 6.63M -1.61M -731.00K -1.31M -16.63M -3.90M -3.88M -2.86M 23.25M
Other Non-Cash Items -6.87M -3.39M -343.00K 45.03M -131.00K 23.00K 7.00K -56.00K 248.00K
Deferred Income Tax - - - -7.49M - -236.00K 17.00K 17.00K -248.00K
Change in Working Capital 11.44M 751.00K 2.02M -5.32M -14.08M -2.15M -2.88M -2.32M 23.88M
Operating Cash Flow -153.62M -118.64M -58.76M -35.85M -41.51M -32.49M -25.84M -18.64M 17.72M
Capital Expenditures -2.80M -6.86M -1.72M - -33.00K -549.00K -912.00K -3.31M -1.99M
Acquisitions - 117.86K - 8.42M 204.00K - - - -
Purchase of Investments -348.80M -177.85M - - -204.00K -47.68M -6.50M -55.17M -
Sales Maturities Of Investments 253.78M 60.00M - - 22.99M 37.70M 21.00M 28.00M -
Other Investing Acitivies - -117.86K - 8.42K 204.00K - -75.00K 50.00K -1.25M
Investing Cash Flow -97.82M -124.72M -1.72M 8.42M 23.16M -10.53M 13.51M -30.43M -3.25M
Debt Repayment - - - - - - - - -
Common Stock Repurchased - - - - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies 1.72M 1.61M -30.00K 99.47M 108.00K -1.45M -789.00K -40.00K 70.75M
Financial Cash Flow 163.54M 163.56M 37.98M 232.20M 108.00K 70.35M -729.00K -40.00K 70.75M
Net Cash Flow -87.91M -79.80M -22.51M 204.77M -18.25M 27.33M -13.05M -49.11M 85.22M
Free Cash Flow -156.42M -125.50M -60.48M -35.85M -41.55M -33.04M -26.75M -21.95M 15.72M